arrow
T

Thomas M. Jenkins

Sheffield Institute for Translational Neuroscience
H指数:30
被引数:2,690

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Understanding the uptake and use of noninvasive ventilation among Australians living with amyotrophic lateral sclerosis: results of a national survey

了解澳大利亚肌萎缩侧索硬化症患者非侵入性通气的使用和采纳情况:一项全国性调查的结果

2025-07-260
OA
Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS-A multicentre case-control study

新型冠状病毒肺炎神经或精神并发症患者的长期功能预后较差: covid-cns-一项多中心病例对照研究

2025-01-270
OAAI
Utilising accessible and reproducible neurological assessments in clinical studies: Insights from use of the Neurological Impairment Scale in the multi-centre COVID-CNS study

在临床研究中使用可访问和可重复的神经系统评估: 在多中心covid-cns研究中使用神经功能缺损量表的见解

2024-09-010
OAAI
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study

解决英国神经学研究中的种族差异: 前瞻性多中心新型冠状病毒肺炎临床神经科学研究的一个例子

2024-05-011
OAAI
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
2023-05-2918
OAAI
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

肌萎缩侧索硬化生物流体生物标志物的多中心评估显示血液神经丝轻链的首要性

2022-02-0951
OAAI
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

肌萎缩侧索硬化患者系统基因筛查的价值

2021-02-1481
OAAI